Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
Amazon Secures 200 MW Wind Power Deals in Sweden 
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
Meta, U.S. States Discuss Settlement in Teen Addiction Trial 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
Jefferies Names AMEC Top China Semiconductor Equipment Pick 
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns 
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake 
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
Add as a preferred source on Google
PLAINSBORO, N.J., April 11, 2018 -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will release first quarter 2018 financial results on Wednesday, April 25, 2018, prior to market open. In conjunction with the earnings release, Integra will host a conference call at 8:30 a.m. ET.
Peter J. Arduini, president and chief executive officer, and Glenn Coleman, chief financial officer and corporate vice-president of International, will review first quarter 2018 results during the call.
The live call is accessible by dialing (323) 794-2093 and using the passcode 5958152. A simultaneous webcast of the call will be available via the Company’s website at www.integralife.com.
A webcast replay of the call can be accessed through the Investor Relations homepage of Integra's website at www.integralife.com. A replay of the call will be available through April 30, 2018 by dialing (719) 457-0820 and using the passcode 5958152.
About Integra LifeSciences
Integra LifeSciences is a global leader in regenerative technologies, neurosurgical and extremity orthopedic solutions dedicated to limiting uncertainty for clinicians, so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Bactiseal®, Cadence®, Certas™, Codman®, CUSA®, DuraGen®, DuraSeal®, ICP Express®, Integra®, MediHoney®, MicroFrance®, PriMatrix®, Salto Talaris®, SurgiMend®, TCC-EZ®, Titan™ and VersaTru™. For the latest news and information about Integra and its brands, please visit www.integralife.com.
Investor Relations:
Michael Beaulieu
Director, Investor Relations
(609) 750-2827
[email protected]
Media Contact:
Laurene Isip
Senior Director, Global Corporate Communications
(609) 750-7984
[email protected]
